Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
Jun Iwamoto,1 Yoshihiro Sato21Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, JapanAbstract: An open-label randomized controlled trial was conducted to clarify the effect of eldecalcitol (ED) on body bal...
Main Authors: | Iwamoto J, Sato Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-01-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/eldecalcitol-improves-chair-rising-time-in-postmenopausal-osteoporotic-a15538 |
Similar Items
-
Combined Use of Ibandronate and Eldecalcitol in Postmenopausal Japanese Women with Osteoporosis
by: Junichi Takada, et al.
Published: (2016-12-01) -
The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
by: Zaoqian Zheng, et al.
Published: (2020-09-01) -
Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
by: Zaoqian Zheng, et al.
Published: (2020-09-01) -
Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
by: Mikio Kamimura, et al.
Published: (2019-06-01) -
A postmenopausal osteoporotic woman losing bone mineral density despite bisphosphonates
by: Lai PSM, et al.
Published: (2013-10-01)